Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Finance Watch: 2020 Is Four Biopharma IPOs Away From Matching 2019

Aug 22 2020

• By Mandy Jackson

Finance Watch

Related Content

Keeping Track: Veklury NDA Arrives At US FDA; Olinvyk Sees Approval; MAb Filings By Regneron, Y-mAbs

Aug 11 2020

Keeping Track: Industry Beefs Up 2020 Review Pipeline With Submissions Galore

Nov 04 2019

AMR Roundtable: Optimism About CARB-X's Success And Prospects For The Future (Part 2)

Jul 18 2017

Coronavirus Update: Pfizer Vaccine Candidates Gain Fast-Track Status

Jul 14 2020

Finance Watch: As Exit Values Rise, More Money Flows Into VC Investments

Jul 15 2020

Sanofi Nabs Kymera IRAK4 Protein Degrader As It Continues To Build In I&I

Jul 09 2020

CanSino Confirms Immune Response For Coronavirus Vaccine But Safety Concerns Remain

Jul 21 2020

Pipeline Watch: Phase III Starts In COVID-19 And Alzheimer's Disease

Jul 17 2020

Equillium Will Study In-Licensed Itolizumab In Three Indications In 2019

Jul 09 2019

Finance Watch: As US IPO Market Gets More Challenging, Two Companies Opt Out

Nov 13 2019

Alzheon IPO To Fund New Phase III Trialling Of Failed Alzheimer's Drug

Mar 19 2018

Finance Watch: Revolution Medicines Continues 2020’s Post-IPO Trend

Feb 21 2020

Finance Watch: Billions Of Dollars In Offerings Despite US Biopharma Stock Slump

Feb 03 2020

Finance Watch: Gossamer Works Around The Shutdown To Price Its $230m IPO

Jan 26 2019

IPO Update: High-Flying Biopharma IPOs Average 77.1% Return Through Q2

Jun 30 2020

Pipeline Watch: Phase III Readout For Avacopan, Phase III Start For Vutrisiran

Dec 03 2019

US/China-based MicuRx Gets $55m Series C Funding For MRX-I Antibiotic

Sep 26 2016

Finance Watch: 2020 Cell And Gene Therapy Funding Already Bests 2019

Aug 12 2020

Alnylam Secures $2bn Financing From Blackstone By Monetizing Inclisiran Royalties

Apr 13 2020

Asia Deal Watch: Simcere, G1 Partner Globally On Myelopreservation Drug

Aug 04 2020

Related Companies

Kymera Therapeutics, Inc.

Inhibrx, Inc.

Harmony Biosciences Holdings, Inc.

Sanofi

CanSino Biologics Inc.

Viva Biotech (Shanghai)

Omeros Corporation

Seres Therapeutics, Inc.

Adverum Biotechnologies, Inc.

Alnylam Pharmaceuticals Inc.

Novartis AG

Trevena Inc.

Equillium, Inc.

Biocon, Ltd.

Tango Therapeutics, Inc.

Gilead Sciences, Inc.

Alzheon Inc.

Shanghai MicuRx Pharmaceuticals Co., Ltd.

Additional Topics

Financing Business Strategies Deals StartUps and SMEs Commercial BioPharmaceutical

More from Financing

More from Business

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window